CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 119 enrolled
Drug / intervention
GP ablation + PV isolationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00584415
NCT00584415N/ACompleted

Navi-Star Thermo-Cool Catheter For Ablation of Atrial Fibrillation

University of Oklahoma·interventional·Posted Jan 2, 2008·Updated Jul 28, 2014

In Brief

A clinical study evaluating GP ablation + PV isolation for Paroxysmal Atrial Fibrillation. Completed, enrolled 119 participants across 1 site.

Detailed Summary

The objective of this study is to demonstrate that the NAVI-STAR THERMO-COOL catheter can be used to safely and effectively reduce symptomatic episodes of paroxysmal atrial fibrillation in patients with frequent (\>3 episodes/month) or infrequent \<3 episodes/month)atrial fibrillation resistant to at least one Class I or Class III antiarrhythmic drug.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 2, 2008
Enrollment StartFeb 1, 2004
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 18.5 years ago

Interventions

GP ablation + PV isolationdevice

All patients underwent GP ablation and PV isolation using the NaviStar ThermoCool ablation catheter